Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index; 32 of the 81 sources its claims cite were checked for support.
Abstract
Objectives: The aim of this review is to establish the effectiveness of psychological relapse prevention interventions, as stand-alone interventions and in combination with maintenance antidepressant treatment (M-ADM) or antidepressant medication (ADM) discontinuation for patients with remitted anxiety disorders or major depressive disorders (MDD). Methods: A systematic review and a meta-analysis were conducted. A literature search was conducted in PubMed, PsycINFO and Embase for randomised controlled trials (RCTs) comparing psychological relapse prevention interventions to treatment as usual (TAU), with the proportion of relapse/recurrence and/or time to relapse/recurrence as outcome measure. Results: Thirty-six RCTs were included. During a 24-month period, psychological interventions significantly reduced risk of relapse/recurrence for patients with remitted MDD (RR 0.76, 95% CI: 0.68–0.86, p<0.001). This effect persisted with longer follow-up periods, although these results were less robust. Also, psychological interventions combined with M-ADM significantly reduced relapse during a 24-month period (RR 0.76, 95% CI: 0.62–0.94, p = 0.010), but this effect was not significant for longer follow-up periods. No meta-analysis could be performed on relapse prevention in anxiety disorders, as only two studies focused on relapse prevention in anxiety disorders. Conclusions: In patients with remitted MDD, psychological relapse prevention interventions substantially reduce risk of relapse/recurrence. It is recommended to offer these interventions to remitted MDD patients. Studies on anxiety disorders are needed. Systematic review registration number: PROSPERO 2018: CRD42018103142 .
Overview
CoChat Summary
TL;DR
This systematic review and meta-analysis found that psychological relapse prevention interventions reduce relapse/recurrence in remitted major depressive disorder (MDD), with a 24% relative risk reduction versus treatment as usual up to 24 months. Evidence in remitted anxiety disorders was too scarce for meta-analysis, and longer-term add-on effects to maintenance antidepressants were not significant.
Key findings
- In remitted MDD, psychological interventions versus TAU reduced relapse/recurrence over ≤24 months: RR 0.76 (95% CI 0.68–0.86, p<0.001; I²=25.312), based on 21 comparisons and 2,715 patients; summary relapse prevalence was 34.7% vs 47.2%.
- The effect persisted at >24 months (mean 38.6 months): RR 0.78 (95% CI 0.62–0.98, p=0.036), with greater heterogeneity (I²=61.261).
- Psychological interventions plus maintenance antidepressant medication (M-ADM) versus M-ADM alone reduced relapse over ≤24 months: RR 0.76 (95% CI 0.62–0.94, p=0.010), but not at >24 months: RR 0.87 (95% CI 0.62–1.21, p=0.396).
- Only two anxiety disorder studies were found and no meta-analysis was performed; one reported lower relapse with maintenance CBT (5.2% vs 18.4%), while the other found no significant difference (67% vs 65%).
Methods
- Systematic review and meta-analysis of RCTs in adults (≥18 years) with remitted anxiety disorder or MDD, comparing psychological relapse prevention interventions to TAU, with relapse/recurrence and/or time to relapse as outcomes; searches in PubMed, PsycINFO, and Embase from inception to July 2021.
- Thirty-six RCTs (40 comparisons) were included; 35 comparisons entered quantitative synthesis. Analyses used random-effects models and risk ratios with 95% CIs, based on intention-to-treat data, with separate analyses for ≤24 months and >24 months.
- Planned subgroup and meta-regression analyses examined prior intervention, intervention type, setting, delivery mode, number of previous episodes, and intervention duration; anxiety and antidepressant-discontinuation studies were described qualitatively because meta-analysis was not possible.
Limitations
- The paper states that some planned analyses could not be performed due to incomplete data, including anxiety disorders and psychological interventions combined with antidepressant discontinuation.
- The paper states that included studies differed in definitions of relapse/remission and measures used, potentially causing heterogeneity; evidence of publication bias was found, though it did not significantly change the estimated effect size.
- The paper states it could not determine whether effects were due to more therapy sessions versus intervention content; the text also makes evident that anxiety disorder evidence is limited to two contradictory studies, and all studies had high risk of performance bias because psychological interventions could not be concealed from participants and personnel.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
19 Valid · 2 Not valid · 13 Not checked · 69 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Likewise, with regard to major depressive disorder (MDD), 18–77% of patients experienced a relapse [22–28].”
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Introduction
What the sources say
- Partly supportedcites [22] HJ Conradi, 2017, The ten-year course of depression in primary care and long-term effects of psychoeducation, psychiatric consultation and cognitive behavioral therapy, Journal of Affective Disorders sourceExperimental — accuracy not yet measured
Section 3.3 reports that 76.5% of patients had a new major depressive episode during the ten-year follow-up, supporting the upper end of the cited range. The paper does not report an 18% relapse rate, so it does not support the full 18–77% range on its own. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [23] S Gopinath, 2007, Clinical factors associated with relapse in primary care patients with chronic or recurrent depression, Journal of Affective Disorders source
- Partly supportedcites [24] F Hardeveld, 2013, Recurrence of major depressive disorder across different treatment settings: Results from the NESDA study, Journal of Affective Disorders sourceExperimental — accuracy not yet measured
Section 3.2 (page unavailable) reports that 26.8% of patients in primary care and 33.5% in specialized mental health care experienced a recurrence during two years. Those figures fall within the cited range, but this paper does not report its 18% or 77% endpoints, and it describes recurrence after remission rather than relapse. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [25] J Yiend, 2009, Long term outcome of primary care depression, Journal of Affective Disorders source
- Disputedcites [26] R Saunders, 2021, A Patient Stratification Approach to Identifying the Likelihood of Continued Chronic Depression and Relapse Following Treatment for Depression, Journal of Personalized Medicine sourceExperimental — accuracy not yet measured
The Discussion reports relapse likelihoods of 17.5%–45.7% across patient profiles, not 18%–77%. Its 77.5% figure refers to continued chronic depression, a separate outcome defined in Methods §2.3. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [27] S Ali, 2017, How durable is the effect of low intensity CBT for depression and anxiety? Remission and relapse in a longitudinal cohort study, Behaviour Research and Therapy sourceExperimental — accuracy not yet measured
The Time-to-event analysis reports that 52.8% of cases relapsed within 12 months, which falls within the claimed range. But the Sample characteristics and Outcome definitions describe a cohort with depression and/or anxiety, not an MDD-only relapse rate; the paper does not establish the 18–77% bounds. (LLM, conf=0.86)
- Partly supportedcites [28] JEJ Buckman, 2019, Attentional Control as a Predictor of Response to Psychological Treatment for Depression and Relapse up to 1 year After Treatment: A Pilot Cohort Study, Behavioural and Cognitive Psychotherapy sourceExperimental — accuracy not yet measured
The Results (Descriptive statistics; page unavailable) report that 7 of 33 participants who reached remission after treatment (21.21%) relapsed within one year. That rate falls within the cited range, but this paper does not establish its 18% and 77% endpoints, and its rate applies to participants who reached remission rather than all patients with MDD. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Although characteristics such as having residual symptoms, prior episodes and childhood maltreatment [17] are known to increase relapse risks, mechanisms underlying relapse are still poorly understood.”
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Introduction
What the sources say
- Supportedcites [17] JEJ Buckman, 2018, Risk factors for relapse and recurrence of depression in adults and how they operate: A four-phase systematic review and meta-synthesis, Clinical Psychology Review source
The General discussion identifies residual depressive symptoms, childhood maltreatment, and a history of recurrence as factors associated with increased relapse or recurrence risk. Study 2’s Discussion also reports higher risk among patients with prior episodes than among those in their first episode; the claim does not assert that risk rises with every additional episode. (LLM, conf=0.92)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In anxiety disorders, after remission, 14–58% of patients experienced a relapse [5, 8, 12, 20, 21], with similar relapse rates for subtypes of anxiety disorders [5].”
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Introduction
What the sources say
- Not checked — no full text of the sourcecites [5] WD Scholten, 2013, Recurrence of anxiety disorders and its predictors, Journal of Affective Disorders source
- Partly supportedcites [8] BWJH Penninx, 2011, Two-year course of depressive and anxiety disorders: Results from the Netherlands Study of Depression and Anxiety (NESDA), Journal of Affective Disorders sourceExperimental — accuracy not yet measured
Section 3.1 reports recurrence after remission in 21.9% of the anxiety-only group and 23.8% of the comorbid group, supporting a rate within the cited range. It does not establish the 14–58% range or report similar relapse rates across anxiety-disorder subtypes; its comparison is between anxiety-only and comorbid groups. (LLM, conf=0.86)
- Partly supportedcites [12] SE Bruce, 2005, Influence of Psychiatric Comorbidity on Recovery and Recurrence in Generalized Anxiety Disorder, Social Phobia, and Panic Disorder: A 12-Year Prospective Study, American Journal of Psychiatry sourceExperimental — accuracy not yet measured
The Results report 12-year recurrence probabilities of 39%, 45%, 56%, and 58% after recovery, supporting recurrence up to 58% but not the stated 14% lower bound. They describe similar rates for the two panic-disorder subtypes (56% and 58%), while noting lower rates for social phobia and generalized anxiety disorder; thus similarity across all subtypes is not established. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [20] HC Levy, 2021, A meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders, Journal of Anxiety Disorders source
- Partly supportedcites [21] JH Taylor, 2015, Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial, Journal of Psychiatric Research sourceExperimental — accuracy not yet measured
The Discussion reports that 33% of remitted CALM patients had symptom recurrence within a year, and says recurrence rates were similar across anxiety disorders. It does not report the attributed 14–58% range; its overall figure comes from patients treated in primary care. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Patients in the M-CBT group had significantly lower relapse rates (5.2%) compared to those in the assessment-only group (18.4%) at 21-month follow-up.”
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Results > Studies on anxiety disorders
What the sources say
- Supportedcites [56] KS White, 2013, Does maintenance CBT contribute to long-term treatment response of panic disorder with or without agoraphobia? A randomized controlled clinical trial, Journal of Consulting and Clinical Psychology source
The Results section, under “Maintenance Treatment and Its Impact on Outcome at 21 Month Follow-Up,” reports significantly lower relapse rates with M-CBT (5.2%) than with assessment only (18.4%). The study concerned patients who responded to acute CBT for panic disorder with or without agoraphobia. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“The relapse prevention effect was not significant in the other two studies [87, 89].”
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Results > Studies on depressive disorders
What the sources say
- Not checked — no full text of the sourcecites [87] GA Fava, 1994, Cognitive behavioral treatment of residual symptoms in primary major depressive disorder, American Journal of Psychiatry source
- Supportedcites [89] Z V. Segal, 2010, Antidepressant Monotherapy vs Sequential Pharmacotherapy and Mindfulness-Based Cognitive Therapy, or Placebo, for Relapse Prophylaxis in Recurrent Depression, Archives of General Psychiatry source
The Relapse section reports no overall main effect of treatment group on relapse (P=.66), supporting this paper as one of the studies with a nonsignificant overall effect. The result varied by remission status: MBCT significantly reduced relapse relative to placebo among unstable remitters, but not among stable remitters. This paper alone cannot establish the result of the other cited study. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
50 more claims · 5 with their cited sources checked
Create a free account to see all 103 claims and to verify the 6 references still open.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 34
- The quote only partly states this claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specific forms of CBT and pharmacotherapy focused on relapse prevention have been found to significantly reduce relapse for eating, substance use, mood and anxiety disorders (246–255).”
From The integrated treatment of eating disorders, posttraumatic stress disorder, and psychiatric comorbidity: a commentary on the evolution of principles and guidelines (2023) · cites this paper as [250]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Introduction
“To our knowledge, there are no studies in depression directly comparing the addition of psychological interventions to discontinuation of ADM versus discontinuation alone.”
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Results > Studies on depressive disorders
“Three studies were found in which ADM was discontinued in the intervention group, as well as in the TAU group [87–89].”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Results > Characteristics of the studies
“Sample sizes for the 36 studies (40 comparisons) that were included in the meta-analyses ranged from 14 to 460.”
§ Psychological interventions to prevent relapse in anxiety and depression: A systematic review and meta-analysis > Results
“36 studies (40 comparisons) were included in the qualitative synthesis and 35 comparisons were included in the quantitative synthesis (Fig 1).”
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“The study was conducted and reported according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [51].”
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Rayyan-a web and mobile app for systematic reviews.
Ouzzani, M., Hammady, H., Fedorowicz, Z., & Elmagarmid, A. (2016) · Systematic Reviews · doi:10.1186/s13643-016-0384-4 · Cited by 26,092 · cited 1×
“The computer programme ‘Rayyan’ was used to facilitate this process [52].”
MethodDermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2009) · doi:10.1002/9780470743386 · Cited by 14,225
Cumpston, M., Li, T., Page, M. J., Chandler, J., Welch, V. A., Higgins, J. P., & Thomas, J. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.ed000142 · Cited by 7,218
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy.
Teasdale, J. D., Segal, Z. V., Williams, J. M. G., Ridgeway, V. A., Soulsby, J. M., & Lau, M. A. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.68.4.615 · Cited by 3,236
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 2×
“The term ‘relapse’ is used to refer to both relapse and recurrence, as these terms are often used interchangeably [14], indicating a return to full symptoms and meeting the criteria for anxiety disorder or MDD following remission or recovery [15].”
BackgroundInfluentialPRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Ma, S. H., & Teasdale, J. D. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.1.31 · Cited by 1,390
Phillips, L. S., Branch, W. T., Cook, C. B., Doyle, J. P., El-Kebbi, I. M., Gallina, D. L., Miller, C. D., Ziemer, D. C., & Barnes, C. S. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-9-200111060-00012 · Cited by 1,370 · cited 1×
“sexual dysfunction, dry mouth) [38] might be reluctant to adhere to ADM during asymptomatic periods [39].”
BackgroundPractice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
(2008) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.149114 · Cited by 1,028
Risk for recurrence in depression
Burcusa, S. L., & Iacono, W. G. (2007) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.02.005 · Cited by 1,023 · cited 1×
“Most common explanations for the high relapse risk in anxiety disorders and MDD are based on two hypotheses: 1) some individuals have a greater premorbid vulnerability than others (for example due to childhood maltreatment), or b) the ‘scarring-hypothesis’, which suggests that each depressive episodes leaves residual…”
BackgroundBruce, S. E., Yonkers, K. A., Otto, M. W., Eisen, J. L., Weisberg, R. B., Pagano, M., Shea, M. T., & Keller, M. B. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1179 · Cited by 963 · cited 2×
“However, relapse is common in these patients [12, 13], even for those who have adequately responded to treatment in the acute phase.”
BackgroundRelapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 2×
“As many remitted patients use M-ADM, and M-ADM in itself affects relapse rates [36], this comparison is highly relevant for clinical practice.”
BackgroundLamers, F., van Oppen, P., Comijs, H. C., Smit, J. H., Spinhoven, P., van Balkom, A. J. L. M., Nolen, W. A., Zitman, F. G., Beekman, A. T. F., & Penninx, B. W. J. H. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06176blu · Cited by 913 · cited 1×
“Comorbidity among these categories of disorders is high [2], transitions between anxiety and depression are frequent [3–5], these disorders impact upon each other [6–8], and both belong to the internalizing disorders sharing multiple etiological factors and psychopathological processes [9].”
BackgroundPiet, J., & Hougaard, E. (2011) · Clinical Psychology Review · doi:10.1016/j.cpr.2011.05.002 · Cited by 807 · cited 3×
“In addition, we found that MBCT was effective in preventing relapse, as previously reported by Piet and Hougaard [46], Clarke et al.”
ResultMcHugh, R. K., Whitton, S. W., Peckham, A. D., Welge, J. A., & Otto, M. W. (2013) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07757 · Cited by 800 · cited 1×
“Although there are no studies to support this assumption in remitted patients, it is well known that patients engaging in acute treatment have a strong preference for psychological treatment over pharmacological treatment [41].”
BackgroundPrevention of Relapse following cognitive therapy vs medications in moderate to severe depression.
Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Young, P. R., Haman, K. L., Freeman, B. B., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.417 · Cited by 735
Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder
Rush, A. J., Kraemer, H. C., Sackeim, H. A., Fava, M., Trivedi, M. H., Frank, E., Ninan, P. T., Thase, M. E., Gelenberg, A. J., Kupfer, D. J., et al. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301131 · Cited by 707 · cited 1×
“Although a distinction between relapse and recurrence is described in the literature [15, 16], it appears most studies do not distinguish between the two [17].”
BackgroundReynolds III, C. F., Frank, E., Perel, J. M., Imber, S. D., Cornes, C., Miller, M. D., Mazumdar, S., Houck, P. R., Dew, M. A., Stack, J. A., et al. (1999) · JAMA · doi:10.1001/jama.281.1.39 · Cited by 659
Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.475 · Cited by 551
Prevention of Recurrent Depression With Cognitive Behavioral Therapy: Preliminary Findings
Fava, G. A., Rafanelli, C., Grandi, S., Conti, S., & Belluardo, P. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.9.816 · Cited by 491 · cited 2×
“In one study, the relapse rate was significantly lower in the discontinuation plus CBT group (25%), as compared to the discontinuation group (80%) [88].”
BackgroundResultMaintenance Treatment of Major Depression in Old Age
Reynolds, C. F., Dew, M. A., Pollock, B. G., Mulsant, B. H., Frank, E., Miller, M. D., Houck, P. R., Mazumdar, S., Butters, M. A., Stack, J. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052619 · Cited by 476 · cited 1×
“IPT was not included in the subgroup analysis for type of intervention, as only one study was available with results up to and including 24 months [62].”
MethodSegal, Z. V., Bieling, P., Young, T., MacQueen, G., Cooke, R., Martin, L., Bloch, R., & Levitan, R. D. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.168 · Cited by 429 · cited 1×
“The relapse prevention effect was not significant in the other two studies [87, 89].”
ResultTreating Major Depression in Primary Care Practice: Eight-Month Clinical Outcomes
Schulberg, H. C. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830100061008 · Cited by 426
Williams, J. M. G., Crane, C., Barnhofer, T., Brennan, K., Duggan, D. S., Fennell, M. J. V., Hackmann, A., Krusche, A., Muse, K., Von Rohr, I. R., et al. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0035036 · Cited by 420 · cited 1×
“One study had two intervention groups and one control group [64].”
BackgroundBuckman, J. E. J., Underwood, A., Clarke, K., Saunders, R., Hollon, S. D., Fearon, P., & Pilling, S. (2018) · Clinical Psychology Review · doi:10.1016/j.cpr.2018.07.005 · Cited by 398 · cited 3×
“Although characteristics such as having residual symptoms, prior episodes and childhood maltreatment [17] are known to increase relapse risks, mechanisms underlying relapse are still poorly understood.”
BackgroundModels of comorbidity for multifactorial disorders.
Neale, M. C., & Kendler, K. S. (1995) · PubMed · Cited by 357
Penninx, B. W. J. H., Nolen, W. A., Lamers, F., Zitman, F. G., Smit, J. H., Spinhoven, P., Cuijpers, P., de Jong, P. J., van Marwijk, H. W. J., der Meer, K. V., et al. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.027 · Cited by 354 · cited 3×
“In anxiety disorders, after remission, 14–58% of patients experienced a relapse [5, 8, 12, 20, 21], with similar relapse rates for subtypes of anxiety disorders [5].”
BackgroundGodfrin, K. A., & van Heeringen, C. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.04.006 · Cited by 296
Jarrett, R. B., Kraft, D., Doyle, J., Foster, B. M., Eaves, G. G., & Silver, P. C. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.381 · Cited by 293
Tapering of SSRI treatment to mitigate withdrawal symptoms
Horowitz, M. A., & Taylor, D. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30032-x · Cited by 280
Cognitive behavioral treatment of residual symptoms in primary major depressive disorder
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.9.1295 · Cited by 266 · cited 1×
“The relapse prevention effect was not significant in the other two studies [87, 89].”
ResultBockting, C. L. H., DELTA Study Group, Schene, A. H., Spinhoven, P., Koeter, M. W. J., Wouters, L. F., Huyser, J., & Kamphuis, J. H. (2005) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.73.4.647 · Cited by 249
Side effects of antidepressants during long-term use in a naturalistic setting
Bet, P. M., Hugtenburg, J. G., Penninx, B. W. J. H., & Hoogendijk, W. J. G. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.05.001 · Cited by 239 · cited 1×
“sexual dysfunction, dry mouth) [38] might be reluctant to adhere to ADM during asymptomatic periods [39].”
BackgroundBondolfi, G., Jermann, F., der Linden, M. V., Gex-Fabry, M., Bizzini, L., Rouget, B. W., Myers-Arrazola, L., Gonzalez, C., Segal, Z., Aubry, J.-M., et al. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.07.007 · Cited by 223
Sim, K., Lau, W. K., Sim, J., Sum, M. Y., & Baldessarini, R. J. (2016) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv076 · Cited by 218 · cited 1×
“Third, more research is needed on effective relapse prevention interventions combined with discontinuation of ADM, as most patients have reservations about the long-term use of medication [98], even though the risk of relapse during discontinuation is high [37].”
BackgroundPractice Guideline for the Treatment of Patients With Panic Disorder
(2007) · APA Practice Guidelines for the Treatment of Psychiatric Disorders: Comprehensive Guidelines and Guideline Watches · doi:10.1176/appi.books.9780890423363.51396 · Cited by 191
Blackburn, I.-M., & Moore, R. G. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.4.328 · Cited by 179
Biesheuvel-Leliefeld, K. E. M., Kok, G. D., Bockting, C. L. H., Cuijpers, P., Hollon, S. D., van Marwijk, H. W. J., & Smit, F. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.016 · Cited by 175 · cited 7×
“For example, it has not been consistently examined and reported whether relapse prevention interventions are more effective for patients who have received other interventions prior to the relapse prevention intervention [18, 44, 48].”
BackgroundResultInfluentialStangier, U., Hilling, C., Heidenreich, T., Risch, A. K., Barocka, A., Schlösser, R., Kronfeld, K., Ruckes, C., Berger, H., Röschke, J., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060734 · Cited by 174
Guidi, J., Tomba, E., & Fava, G. A. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15040476 · Cited by 167
Segal, Z. V., Dimidjian, S., Beck, A., Boggs, J. M., Vanderkruik, R., Metcalf, C. A., Gallop, R., Felder, J. N., & Levy, J. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4693 · Cited by 159
Batelaan, N. M., Bosman, R. C., Muntingh, A., Scholten, W. D., Huijbregts, K. M., & van Balkom, A. J. L. M. (2017) · BMJ · doi:10.1136/bmj.j3927 · Cited by 153
Self-citationRecurrence of anxiety disorders and its predictors
Scholten, W. D., Batelaan, N. M., van Balkom, A. J., WJH. Penninx, B., Smit, J. H., & van Oppen, P. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.10.031 · Cited by 146 · cited 1×
“In anxiety disorders, after remission, 14–58% of patients experienced a relapse [5, 8, 12, 20, 21], with similar relapse rates for subtypes of anxiety disorders [5].”
BackgroundSelf-citationAli, S., Rhodes, L., Moreea, O., McMillan, D., Gilbody, S., Leach, C., Lucock, M., Lutz, W., & Delgadillo, J. (2017) · Behaviour Research and Therapy · doi:10.1016/j.brat.2017.04.006 · Cited by 139
Klein, D. N., Santiago, N. J., Vivian, D., Blalock, J. A., Kocsis, J. H., Markowitz, J. C., McCullough, J. P., Rush, A. J., Trivedi, M. H., Arnow, B. A., et al. (2004) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.72.4.681 · Cited by 138
PAYKEL, E. S., SCOTT, J., CORNWALL, P. L., ABBOTT, R., CRANE, C., POPE, M., & JOHNSON, A. L. (2005) · Psychological Medicine · doi:10.1017/s003329170400282x · Cited by 136 · cited 1×
“Of these three studies, one was a follow-up to another study that was included in the meta-analysis up to and including 24 months [70].”
BackgroundScholten, W. D., Batelaan, N. M., Penninx, B. W. J. H., Balkom, A. J. L. M. V., Smit, J. H., Schoevers, R. A., & Oppen, P. V. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.025 · Cited by 125
Self-citationVerduijn, J., Verhoeven, J. E., Milaneschi, Y., Schoevers, R. A., van Hemert, A. M., Beekman, A. T. F., & Penninx, B. W. J. H. (2017) · BMC Medicine · doi:10.1186/s12916-017-0972-8 · Cited by 122 · cited 1×
“However, relapse is common in these patients [12, 13], even for those who have adequately responded to treatment in the acute phase.”
BackgroundGuidi, J., Fava, G. A., Fava, M., & Papakostas, G. I. (2011) · Psychological Medicine · doi:10.1017/s0033291710000826 · Cited by 118 · cited 1×
“Previous meta-analyses contain very little information about the effectiveness of adding psychological interventions to M-ADM or the discontinuation of ADM, even though this approach could be promising for preventing relapse [49, 50].”
MethodBockting, C. L. H., Spinhoven, P., Wouters, L. F., Koeter, M. W. J., Schene, A. H., & DELTA Study Group (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04784blu · Cited by 113 · cited 1×
“Three studies in this meta-analysis were follow-ups to studies that were included in the main analysis [66, 68, 72].”
ResultClarke, K., Mayo-Wilson, E., Kenny, J., & Pilling, S. (2015) · Clinical Psychology Review · doi:10.1016/j.cpr.2015.04.002 · Cited by 113 · cited 6×
“For example, it has not been consistently examined and reported whether relapse prevention interventions are more effective for patients who have received other interventions prior to the relapse prevention intervention [18, 44, 48].”
BackgroundResultInfluentialHolländare, F., Johnsson, S., Randestad, M., Tillfors, M., Carlbring, P., Andersson, G., & Engström, I. (2011) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2011.01698.x · Cited by 111
Gopinath, S., Katon, W. J., Russo, J. E., & Ludman, E. J. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.10.023 · Cited by 111
Borges, S., Chen, Y.-F., Laughren, T. P., Temple, R., Patel, H. D., David, P. A., Mathis, M., Unger, E., Yang, P., & Khin, N. A. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08722 · Cited by 109 · cited 1×
“The term ‘relapse’ is used to refer to both relapse and recurrence, as these terms are often used interchangeably [14], indicating a return to full symptoms and meeting the criteria for anxiety disorder or MDD following remission or recovery [15].”
Backgroundten Have, M., de Graaf, R., van Dorsselaer, S., Tuithof, M., Kleinjan, M., & Penninx, B. W. J. H. (2018) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12874 · Cited by 106 · cited 1×
“This is especially relevant as the risk of relapse persists over time [97].”
BackgroundZhang, Z., Zhang, L., Zhang, G., Jin, J., & Zheng, Z. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1610-5 · Cited by 99 · cited 4×
“Secondly, in contrast to other meta-analyses [18, 44, 48], we included more recent trials in our analyses, addressing not only patients suffering from MDD but also from anxiety disorders.”
BackgroundResultInfluentialHardeveld, F., Spijker, J., De Graaf, R., Hendriks, S. M., Licht, C. M. M., Nolen, W. A., Penninx, B. W. J. H., & Beekman, A. T. F. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.11.008 · Cited by 95
A meta-analysis of relapse rates in cognitive-behavioral therapy for anxiety disorders
Levy, H. C., O’Bryan, E. M., & Tolin, D. F. (2021) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2021.102407 · Cited by 91 · cited 1×
“In anxiety disorders, after remission, 14–58% of patients experienced a relapse [5, 8, 12, 20, 21], with similar relapse rates for subtypes of anxiety disorders [5].”
BackgroundVan Leeuwen, E., van Driel, M. L., Horowitz, M. A., Kendrick, T., Donald, M., De Sutter, A. I., Robertson, L., & Christiaens, T. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495.pub2 · Cited by 90 · cited 1×
“The frequent occurrence of discontinuation symptoms and relapse after discontinuation [42, 43] might play a part in this preference.”
BackgroundFava, G. A., Ruini, C., Rafanelli, C., & Grandi, S. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2094 · Cited by 88
Adherence to continuation and maintenance antidepressant use in recurrent depression
ten Doesschate, M. C., Bockting, C. L. H., & Schene, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.011 · Cited by 86 · cited 1×
“Indeed, non-adherence to ADM is common among remitted patients [40].”
BackgroundPile, V., Williamson, G., Saunders, A., Holmes, E. A., & Lau, J. Y. F. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00195-4 · Cited by 86 · cited 1×
“Although some evidence based interventions seem to affect mechanisms underlying change and hence potentially change the risk of relapse [30], not all effective treatments in the acute phase guarantee a good prognosis over time in all patients.”
BackgroundShallcross, A. J., Gross, J. J., Visvanathan, P. D., Kumar, N., Palfrey, A., Ford, B. Q., Dimidjian, S., Shirk, S., Holm-Denoma, J., Goode, K. M., et al. (2015) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000050 · Cited by 81
The Challenges of Improving Treatments for Depression
Cuijpers, P. (2018) · JAMA · doi:10.1001/jama.2018.17824 · Cited by 78 · cited 1×
“In recent decades, many treatments for anxiety and depression in the acute phase have proven effective [10, 11].”
BackgroundVerbeek-Heida, P. M., & Mathot, E. F. (2006) · Chronic Illness · doi:10.1177/17423953060020020801 · Cited by 75
Bandelow, B., Sagebiel, A., Belz, M., Görlich, Y., Michaelis, S., & Wedekind, D. (2018) · The British Journal of Psychiatry · doi:10.1192/bjp.2018.49 · Cited by 70 · cited 1×
“In recent decades, many treatments for anxiety and depression in the acute phase have proven effective [10, 11].”
BackgroundCONRADI, H. J., de JONGE, P., KLUITER, H., SMIT, A., van der MEER, K., JENNER, J. A., van OS, T. W. D. P., EMMELKAMP, P. M. G., & ORMEL, J. (2007) · Psychological Medicine · doi:10.1017/s0033291706009809 · Cited by 69
Long term outcome of primary care depression
Yiend, J., Paykel, E., Merritt, R., Lester, K., Doll, H., & Burns, T. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.026 · Cited by 67
Two-year outcome of internet-based relapse prevention for partially remitted depression
Holländare, F., A. Anthony, S., Randestad, M., Tillfors, M., Carlbring, P., Andersson, G., & Engström, I. (2013) · Behaviour Research and Therapy · doi:10.1016/j.brat.2013.08.002 · Cited by 61 · cited 1×
“Three studies in this meta-analysis were follow-ups to studies that were included in the main analysis [66, 68, 72].”
ResultBockting, C., Smid, N. H., Koeter, M. W. J., Spinhoven, P., Beck, A. T., & Schene, A. H. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.06.048 · Cited by 56 · cited 1×
“Further research is required to understand the working mechanism of psychological relapse prevention interventions [96].”
BackgroundHovenkamp-Hermelink, J. H., Riese, H., van der Veen, D. C., Batelaan, N. M., Penninx, B. W., & Schoevers, R. A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.10.035 · Cited by 49
Self-citationReducing Relapse in Depressed Outpatients with Atypical Features: A Pilot Study
Jarrett, R. B., Kraft, D., Schaffer, M., Witt-Browder, A., Risser, R., Atkins, D. H., & Doyle, J. (2000) · Psychotherapy and Psychosomatics · doi:10.1159/000012401 · Cited by 48
O’Driscoll, C., Buckman, J. E. J., Fried, E. I., Saunders, R., Cohen, Z. D., Ambler, G., DeRubeis, R. J., Gilbody, S., Hollon, S. D., Kendrick, T., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-01971-0 · Cited by 46
White, K. S., Payne, L. A., Gorman, J. M., Shear, M. K., Woods, S. W., Saksa, J. R., & Barlow, D. H. (2013) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0030666 · Cited by 42 · cited 3×
“This was the case for anxiety disorders as only two studies were found regarding the effectiveness of psychological interventions for the prevention of relapse of anxiety disorders [55, 56], and for studies in which ADM was discontinued, that additionally had different follow-up durations.”
BackgroundResultBreedvelt, J. J. F., Brouwer, M. E., Harrer, M., Semkovska, M., Ebert, D. D., Cuijpers, P., & Bockting, C. L. H. (2021) · The British Journal of Psychiatry · doi:10.1192/bjp.2020.198 · Cited by 41 · cited 3×
“Although meta-analyses have reported results of studies allowing the use of M-ADM, only one meta-analysis studied the effect of adding psychological interventions to ADM, and found that this significantly reduces relapse risks when compared to ADM only [50].”
MethodResultPsychoeducation for major depressive disorders: A randomised controlled trial
Morokuma, I., Shimodera, S., Fujita, H., Hashizume, H., Kamimura, N., Kawamura, A., Nishida, A., Furukawa, T. A., & Inoue, S. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.05.018 · Cited by 41
Cognitive-behavior therapy for depression: The effects of booster sessions on relapse
Baker, A., & Wilson, P. H. (1985) · Behavior Therapy · doi:10.1016/s0005-7894(85)80001-0 · Cited by 40
Wilkinson, P., Alder, N., Juszczak, E., Matthews, H., Merritt, C., Montgomery, H., Howard, R., Macdonald, A., & Jacoby, R. (2009) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2076 · Cited by 36
Scholten, W. D., Batelaan, N. M., van Oppen, P., Smit, J. H., Hoogendoorn, A. W., van Megen, H. J. G. M., Cath, D. C., & van Balkom, A. J. L. M. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000489498 · Cited by 33 · cited 3×
“This was the case for anxiety disorders as only two studies were found regarding the effectiveness of psychological interventions for the prevention of relapse of anxiety disorders [55, 56], and for studies in which ADM was discontinued, that additionally had different follow-up durations.”
MethodResultSelf-citationShallcross, A. J., Willroth, E. C., Fisher, A., Dimidjian, S., Gross, J. J., Visvanathan, P. D., & Mauss, I. B. (2018) · Behavior Therapy · doi:10.1016/j.beth.2018.02.001 · Cited by 31 · cited 1×
“Three studies in this meta-analysis were follow-ups to studies that were included in the main analysis [66, 68, 72].”
ResultA clinical staging approach to improving diagnostics in anxiety disorders: Is it the way to go?
Bokma, W. A., Batelaan, N. M., Hoogendoorn, A. W., Penninx, B. W. J. H., & van Balkom, A. J. L. M. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419887804 · Cited by 31
Self-citationde Jonge, M., Bockting, C., Kikkert, M., van Dijk, M. K., van Schaik, A., Peen, J., Hollon, S. D., & Dekker, J. (2019) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000395 · Cited by 30
Biesheuvel-Leliefeld, K. E. M., Dijkstra-Kersten, S. M. A., van Schaik, D. J. F., van Marwijk, H. W. J., Smit, F., van der Horst, H. E., & Bockting, C. L. H. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000472260 · Cited by 29
Predictors of anxiety recurrence in the Coordinated Anxiety Learning and Management (CALM) trial
Taylor, J. H., Jakubovski, E., & Bloch, M. H. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.03.020 · Cited by 25 · cited 1×
“In anxiety disorders, after remission, 14–58% of patients experienced a relapse [5, 8, 12, 20, 21], with similar relapse rates for subtypes of anxiety disorders [5].”
BackgroundConradi, H. J., Bos, E. H., Kamphuis, J. H., & de Jonge, P. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.03.064 · Cited by 25
Saunders, R., Cohen, Z. D., Ambler, G., DeRubeis, R. J., Wiles, N., Kessler, D., Gilbody, S., Hollon, S. D., Kendrick, T., Watkins, E., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11121295 · Cited by 21
Prevention of Relapse in Residual Depression by Cognitive Therapy: A Controlled Trial
Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., Jenaway, A., Cornwall, P. L., Hayhurst, H., Abbott, R., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.9.829 · Cited by 20
Klein, N. S., Kok, G. D., Burger, H., van Valen, E., Riper, H., Cuijpers, P., Dekker, J., Smit, F., van der Heiden, C., & Bockting, C. L. H. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000485039 · Cited by 20
Relapse prevention for depression.
(2010) · American Psychological Association eBooks · doi:10.1037/12082-000 · Cited by 18 · cited 1×
“[18] suggest that this might be a result of a limited dissemination of these terms, although it might also be due to the fact that a distinction between the terms is not supported by evidence from intervention trials [19].”
BackgroundBuckman, J. E. J., Saunders, R., Fearon, P., Leibowitz, J., & Pilling, S. (2019) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s1352465818000590 · Cited by 18
Verbeek-Heida, P. M., & Mathot, E. F. (2006) · Chronic Illness · doi:10.1179/174592006x111003 · Cited by 16
Petersen, T. J., Pava, J. A., Buchin, J., Matthews, J. D., Papakostas, G. I., Nierenberg, A. A., Holmes, A. J., Bogdan, R., Graves, L. M., Harley, R. M., et al. (2010) · Cognitive Therapy and Research · doi:10.1007/s10608-007-9166-6 · Cited by 14
Discontinuation of long-term antidepressant use for depressive and anxiety disorders in adults
Leeuwen, E. V., van Driel, M., Sutter, A. I. D., Anderson, K., Robertson, L., & Christiaens, T. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013495 · Cited by 6
Research works printed but not linked: 4
- National Institute for Health and Care Excellence. The Nice Guideline on the Treatment and Management of Depression in Adults (updated edition). 2010.
- P. Cuijpers, 2016, A practical guide
- M Borenstein, 2013, Comprehensive Meta-Analysis Version 3
- Z V. Segal, 2020, Outcomes of Online Mindfulness-Based Cognitive Therapy for Patients With Residual Depressive Symptoms, JAMA Psychiatry
Cited by
Brewerton, T. D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1149433 · Cited by 46
Treatments for partial remission of major depressive disorder: a systematic review and meta-analysis
Gülpen, J., Brouwer, M. E., Geurtsen, G. J., van Dis, E. A. M., Denys, D. A. J. P., & Bockting, C. (2023) · BMJ Mental Health · doi:10.1136/bmjment-2023-300827 · Cited by 15
Rostamian, S., Heidari-Soureshjani, S., & Sherwin, C. M. T. (2023) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524923666230823094403 · Cited by 14
Defo, S. H. T., Djaouda, M., Bouvourné, P., Nyayi, S. D. G., Camdi, G. W., Kodji, K., Wado, E. K., Abaïssou, H. H. N., & Foyet, H. S. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118940 · Cited by 7
Fi, B., Sumin, A. N., Garganeeva, N. P., Ларева, Н. В., Петрова, М. М., Петрунько, О. В., Попонина, Т. М., Repin, A. N., & Собенников, В. С. (2024) · Complex Issues of Cardiovascular Diseases · doi:10.17802/2306-1278-2024-13-3s-222-253 · Cited by 9
Metadata
- Authors
- Krijnen-de Bruin, E., Scholten, W., Muntingh, A., Maarsingh, O., van Meijel, B., van Straten, A., & Batelaan, N.
- Affiliations
- Amsterdam Public Health (NL)
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-08-12
- Volume
- 17
- Issue
- 8
- Pages
- e0272200
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC9374222
- OpenAlex
- W4290852047
- Semantic Scholar
- 9595aba7b50733a845762d7e91bec6fa2bcb39cd
- Cited by
- 23
- References
- 100
- Citations by year
- 2026: 10 · 2025: 4 · 2024: 4 · 2023: 5
- FWCI
- 0.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion, other-oa)
- Pure Amsterdam UMC (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Data Archiving and Networked Services (DANS) (submittedVersion, cc-by)
- Funders
- Nationaal Regieorgaan Praktijkgericht Onderzoek SIA
- Netherlands Organisation for Scientific Research (NWO, grant number 2015-02-36P)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- relapse prevention, psychological intervention, major depressive disorder, remitted depression, anxiety disorders, antidepressant discontinuation, relapse, recurrence, time to relapse
- MeSH terms
- Psychosocial Intervention, Antidepressive Agents, Anxiety, Anxiety Disorders, Chronic Disease, Depression, Humans, Psychotherapy, Recurrence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

